GRAL

#1860
GRAIL, Inc. Common Stock
43.0600 USD
-2.89%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
43.0600
43.0600
Year Range
41.5000
102.5200
Daily Change
-2.89%
Monthly Change
-56.51%
6 month change
-56.51%
Year Change
-56.51%
Previous Close
44.3400
Open
43.0600
Bid
43.0600
Ask
43.0630
Low
43.0600
High
43.0600
Volume
84
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 1.5826 B
  • Employee 1 000
  • Founded 2015
  • CEO N/A
  • Website www.grail.com
  • Headquarter Delaware, United States
  • FIGI BBG01N6CGW43
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-7.7
Price to sales ratio
—

GRAIL Inc

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021. In June 2021 Galleri launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024.